person
Ángelez P. A.
- Country
- Spain
- Department
- Gastroenterology
Research Overview
assignment
2
Clinical Trials ·
- Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study of Brenipatide (LY3537031) for Efficacy and Safety in Adults with Irritable Bowel Syndrome‑Constipation
- Efficacy and Safety Evaluation of Saccharomyces boulardii CNCM I-745 in Non-Constipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
3
Sites with multiple studies
Has run more than one trial at 3 of 26 partner sites.
Specializations
Functional Gastrointestinal Disorders
Focus on functional gastrointestinal disorders that impact motility and visceral sensitivity.
- Irritable bowel syndrome
- Functional dyspepsia
Emphasis on patient‑reported outcomes and quality‑of‑life measures.
Hepatology and Metabolic Liver Disease
Study of chronic liver conditions linked to metabolic liver disease.
- Non‑alcoholic fatty liver disease
- Primary sclerosing cholangitis
Integration of imaging biomarkers and serum panels for disease staging.
Inflammatory Bowel Disease
Research on immune‑mediated disorders of the intestinal mucosa, particularly inflammatory bowel disease.
- Crohn's disease
- Ulcerative colitis
Collaboration with immunology units to explore biologic therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.